Transcatheter arterial embolization
(TAE) has played a huge role
in interventional therapy and tumor embolization of organ hemorrhage
and accidental hemorrhage. The selection of embolic materials with
better biocompatibility is an important part of TAE. In this work,
we prepared a gelatin microspheres (GMs) embolization material that
simultaneously encapsulates silver sulfide quantum dots (Ag2S QDs) and barium sulfate (BaSO4), giving it good near-infrared
second region (NIR-II) imaging and X-ray imaging effects, while luminescence
effect of NIR-II is better than that of X-ray, which breaks the limitation
of traditional embolization microspheres with only X-ray imaging.
In order to improve the therapeutic effect on tumors, we loaded doxorubicin
(DOX) antitumor drugs inside the microspheres and bound thrombin on
the surface of the microspheres. Thereby, not only can it help achieve
rapid embolization during hemostasis, but its sustained release can
also accelerate tumor necrosis. The microspheres have good biocompatibility
and blood compatibility. Preliminary application results show that
the microspheres can achieve a good embolization effect in the ear
artery and renal artery of New Zealand white rabbits. Thus, they can
be used as a potential embolization system for drug delivery as well
as an effective material for arterial embolization and hemostasis.
Significantly, this work realizes the clinical embolization application
of NIR-II combined with X-ray multimodal imaging technology in biomedical
imaging.